228 related articles for article (PubMed ID: 16498449)
61. NLRP3 Sensing of Diverse Inflammatory Stimuli Requires Distinct Structural Features.
Rahman T; Nagar A; Duffy EB; Okuda K; Silverman N; Harton JA
Front Immunol; 2020; 11():1828. PubMed ID: 32983094
[TBL] [Abstract][Full Text] [Related]
62. Neurological Manifestations in Familial Mediterranean Fever: a Genotype-Phenotype Correlation Study.
Salehzadeh F; Azami A; Motezarre M; Nematdoust Haghi R; Ahmadabadi F
Open Access Rheumatol; 2020; 12():15-19. PubMed ID: 32021503
[TBL] [Abstract][Full Text] [Related]
63. OLT1177 (Dapansutrile), a Selective NLRP3 Inflammasome Inhibitor, Ameliorates Experimental Autoimmune Encephalomyelitis Pathogenesis.
Sánchez-Fernández A; Skouras DB; Dinarello CA; López-Vales R
Front Immunol; 2019; 10():2578. PubMed ID: 31736980
[TBL] [Abstract][Full Text] [Related]
64. Protein interactions of the inflammasome adapter ASC by solution NMR.
Diaz-Parga P; de Alba E
Methods Enzymol; 2019; 625():223-252. PubMed ID: 31455529
[TBL] [Abstract][Full Text] [Related]
65. Kawasaki disease and familial mediterranean fever gene mutations, is there any link?
Salehzadeh F; Mirzarahimi M; Hosseini Asl S; Nematdoust Haghi R
Open Access Rheumatol; 2019; 11():127-131. PubMed ID: 31191052
[No Abstract] [Full Text] [Related]
66. Structure, interactions and self-assembly of ASC-dependent inflammasomes.
de Alba E
Arch Biochem Biophys; 2019 Jul; 670():15-31. PubMed ID: 31152698
[TBL] [Abstract][Full Text] [Related]
67. Familial Mediterranean Fever Gene Mutations and Gout as an Auto-Inflammatory Arthropathy.
Salehzadeh F; Mohammadikebar Y; Haghi RN; Asl SH; Enteshary A
Med Arch; 2019 Feb; 73(1):55-57. PubMed ID: 31097862
[TBL] [Abstract][Full Text] [Related]
68. Inflammatory caspase regulation: maintaining balance between inflammation and cell death in health and disease.
Bolívar BE; Vogel TP; Bouchier-Hayes L
FEBS J; 2019 Jul; 286(14):2628-2644. PubMed ID: 31090171
[TBL] [Abstract][Full Text] [Related]
69. Oral Mucosal Epithelial Cells.
Groeger S; Meyle J
Front Immunol; 2019; 10():208. PubMed ID: 30837987
[No Abstract] [Full Text] [Related]
70. Inflammasome and Caspase-1 Activity Characterization and Evaluation: An Imaging Flow Cytometer-Based Detection and Assessment of Inflammasome Specks and Caspase-1 Activation.
Nagar A; DeMarco RA; Harton JA
J Immunol; 2019 Feb; 202(3):1003-1015. PubMed ID: 30598512
[TBL] [Abstract][Full Text] [Related]
71. Association between MEFV polymorphisms and the susceptibility to ankylosing spondylitis in a Chinese Han population: A case-control study.
Song J; Zhao L; Jiao J; Wei W
Medicine (Baltimore); 2018 Dec; 97(50):e13274. PubMed ID: 30557972
[TBL] [Abstract][Full Text] [Related]
72. Structural Insights of Benzenesulfonamide Analogues as NLRP3 Inflammasome Inhibitors: Design, Synthesis, and Biological Characterization.
Fulp J; He L; Toldo S; Jiang Y; Boice A; Guo C; Li X; Rolfe A; Sun D; Abbate A; Wang XY; Zhang S
J Med Chem; 2018 Jun; 61(12):5412-5423. PubMed ID: 29877709
[TBL] [Abstract][Full Text] [Related]
73. Tranilast directly targets NLRP3 to treat inflammasome-driven diseases.
Huang Y; Jiang H; Chen Y; Wang X; Yang Y; Tao J; Deng X; Liang G; Zhang H; Jiang W; Zhou R
EMBO Mol Med; 2018 Apr; 10(4):. PubMed ID: 29531021
[TBL] [Abstract][Full Text] [Related]
74. TRIM29 promotes DNA virus infections by inhibiting innate immune response.
Xing J; Zhang A; Zhang H; Wang J; Li XC; Zeng MS; Zhang Z
Nat Commun; 2017 Oct; 8(1):945. PubMed ID: 29038422
[TBL] [Abstract][Full Text] [Related]
75. Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders.
Jiang H; He H; Chen Y; Huang W; Cheng J; Ye J; Wang A; Tao J; Wang C; Liu Q; Jin T; Jiang W; Deng X; Zhou R
J Exp Med; 2017 Nov; 214(11):3219-3238. PubMed ID: 29021150
[TBL] [Abstract][Full Text] [Related]
76. Genetic Variability as a Regulator of TLR4 and NOD Signaling in Response to Bacterial Driven DNA Damage Response (DDR) and Inflammation: Focus on the Gastrointestinal (GI) Tract.
Spanou E; Kalisperati P; Pateras IS; Papalampros A; Barbouti A; Tzioufas AG; Kotsinas A; Sougioultzis S
Front Genet; 2017; 8():65. PubMed ID: 28611823
[TBL] [Abstract][Full Text] [Related]
77. Inflammasome expression and cytomegalovirus viremia in critically ill patients with sepsis.
Singh N; Inoue M; Osawa R; Wagener MM; Shinohara ML
J Clin Virol; 2017 Aug; 93():8-14. PubMed ID: 28550722
[TBL] [Abstract][Full Text] [Related]
78. NLR members in inflammation-associated carcinogenesis.
Zhu H; Cao X
Cell Mol Immunol; 2017 May; 14(5):403-405. PubMed ID: 28366939
[No Abstract] [Full Text] [Related]
79. Inflammasomes in Myeloid Cells: Warriors Within.
Jha S; Brickey WJ; Ting JP
Microbiol Spectr; 2017 Jan; 5(1):. PubMed ID: 28102121
[TBL] [Abstract][Full Text] [Related]
80. Identification of a role for TRIM29 in the control of innate immunity in the respiratory tract.
Xing J; Weng L; Yuan B; Wang Z; Jia L; Jin R; Lu H; Li XC; Liu YJ; Zhang Z
Nat Immunol; 2016 Dec; 17(12):1373-1380. PubMed ID: 27695001
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
